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Embedding supervised exercise 
training for men on androgen 
deprivation therapy into standard 
prostate cancer care: a feasibility 
and acceptability study (the 
STAMINA trial)
Sophie Reale1, Rebecca R. Turner1, Eileen Sutton2, Liz Steed3, Stephanie J. C. Taylor3, 
Dylan Morrissey4, Patrick Doherty5, Diana M. Greenfield6, Michelle Collinson7, 
Jenny Hewison8, Janet Brown9, Saïd Ibeggazene1, Malcolm Mason10, Derek J. Rosario11 & 
Liam Bourke1*
Lifestyle interventions involving exercise training offset the adverse effects of androgen deprivation 
therapy in men with prostate cancer. Yet provision of integrated exercise pathways in cancer care 
is sparse. This study assessed the feasibility and acceptability of an embedded supervised exercise 
training intervention into standard prostate cancer care in a single-arm, multicentre prospective 
cohort study. Feasibility included recruitment, retention, adherence, fidelity and safety. Acceptability 
of behaviourally informed healthcare and exercise professional training was assessed qualitatively. 
Despite the imposition of lockdown for the COVID-19 pandemic, referral rates into and adherence 
to, the intervention was high. Of the 45 men eligible for participation, 79% (n = 36) received the 
intervention and 47% (n = 21) completed the intervention before a government mandated national 
lockdown was enforced in the United Kingdom. Patients completed a mean of 27 min of aerobic 
exercise per session (SD = 3.48), at 77% heart rate maximum (92% of target dose), and 3 sets of 10 reps 
of 3 resistance exercises twice weekly for 12 weeks, without serious adverse event. The intervention 
was delivered by 26 healthcare professionals and 16 exercise trainers with moderate to high fidelity, 
and the intervention was deemed highly acceptable to patients. The impact of societal changes due to 
the pandemic on the delivery of this face-to-face intervention remain uncertain but positive impacts of 
embedding exercise provision into prostate cancer care warrant long-term investigation.
Prostate cancer is common—responsible for a quarter of all new diagnoses of male cancers in the  UK1. Around 
50% of cases will be locally advanced or metastatic at presentation. Androgen deprivation therapy (ADT, medical 
castration), remains the cornerstone of therapy, combined with radiotherapy for locally advanced  disease2, with 
taxane-based chemotherapy for metastatic  disease3 or as sole treatment. ADT is effective for prostate cancer; the 
10-year cancer-specific survival for locally advanced prostate cancer is around 55%. For those with metastatic 
prostate cancer, relative survival is however just 30% over 5  years4.
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A recent systematic review assessing adverse effects across the ADT treatment spectrum (including impacts 
of Abiraterone Acetate and Enzalutamide) reported such treatment will significantly increase the risk of adverse 
effects related to musculoskeletal, metabolic, cardiac, nervous system, vascular, hepatobiliary and reproductive 
systems alongside psychiatric and general  disorders5. Such wide-ranging adverse impacts on health inevitably 
translates to negative consequences for men’s quality of life (QoL)6,7.
Of the numerous strategies evaluated, exercise training is the only evidence-based intervention to have dem-
onstrated beneficial effects exceeding clinically relevant thresholds for disease-specific QoL, cardiovascular health 
and other important patient reported outcomes such as cancer-specific  fatigue8,9. Current National Institute of 
Health and Care Excellence guidelines recommend 12-weeks of combined resistance and aerobic exercise as 
standard treatment (NG 131 1.4.19) for men on ADT for prostate  cancer10, based on findings from non-NHS 
(National Health Service)  practice8,11–13. The current European Association of Urology guidelines make similar 
 recommendations14. Nevertheless, there is very little evidence of such provision being part of standard cancer care 
or trial data demonstrating how to maintain long-term  benefits6. A systematic review of randomised controlled 
trials (RCTs) demonstrated important initial effects with such a 12-week exercise programme, but the benefits 
dissipated without behavioural support, primarily instruction on how to perform the behaviour, with practise, 
and goal  setting15. Behavioural support is an essential component of complex exercise interventions to facilitate 
uptake, adoption, maintenance and relapse management of exercise behaviour and maximise adherence to the 
prescribed  dose16. Supervision is essential for safe translation of the reported efficacy via effectiveness trials to 
the wider patient population.
Despite clear national and international best practice clinical guidelines, referral and provision of integrated 
exercise pathways in cancer care is notably sparse and quality assurance is rarely a routine part of  assessment6. 
A previous phase II trial has demonstrated how behaviour change techniques (BCTs) (i.e. goal setting, generali-
sation of target behaviour, prompting self-monitoring and prompting practise) can support inactive men with 
prostate cancer on active surveillance to improve and maintain regular exercise behaviour for up to 12 months 
of follow-up17. However, it is still not known how to embed such pathways into standard prostate cancer care 
or if clinically relevant outcomes can be achieved over long-term follow-up in men with advanced disease. In 
line with recent updated CONSORT  guidance18 the purpose of this study was to assess the acceptability and 
feasibility of embedding a supervised exercise pathway into standard NHS prostate cancer care to meet current 
National Institute of Health and Care Excellence (NG131 1.4.19) best practice recommendations. Data collected 
here will be used to inform a planned definitive trial evaluating the clinical and cost-effectiveness of a tailored 
lifestyle intervention for men with prostate cancer on ADT.
Methods
Study design. The present study was a single-arm multicentre interventional cohort study (18/03/2019, 
ISRCTN15691664) designed to examine the acceptability and feasibility of integrating and delivering exercise 
into standard prostate cancer care, as part of our intervention development process. This study contributes to 
a larger body of work; Supported exercise TrAining for Men with prostate caNcer on Androgen deprivation 
therapy (STAMINA—a National Institute of Health Research funded programme grant for applied research). 
In STAMINA we propose to embed our behaviourally informed and evidence-based lifestyle intervention into 
prostate cancer care. This involves training cancer team members to endorse and support exercise, commu-
nity-based exercise trainers (ETs) to deliver supervised exercise and behavioural support and communication 
between them to provide seamless patient care (see supplementary file 1).
Participants. Participants included (1) men on ADT for the treatment of prostate cancer, (2) healthcare 
professionals (HCPs) involved in diagnosis and/ or treatment and/ or follow-up of men with prostate cancer on 
ADT and (3) community-based ETs. Inclusion and exclusion criteria can be seen in supplementary file 2.
Procedures. Recruitment of participating services. NHS sites and a linked community exercise partner 
(https:// www. nuffi eldhe alth. com) within ~ 16 km radius, were identified from a previously published national 
survey of prostate cancer care  teams6 and chosen to reflect heterogeneity of acute trusts treating prostate cancer 
based on geographical location, prostate cancer management pathways and professional leads. Approvals were 
sought through NHS trusts’ clinical directorate routes, as well as applicable departmental and clinical govern-
ance approvals before inviting HCPs and ETs to participate. Regulatory and ethical approvals, in accordance with 
the Helsinki Declaration, were sought prior to the commencement of research activities (NHS REC reference: 
19/NW/0025).
Recruitment of study participants. Men on ADT for prostate cancer were identified and recruited for exercise 
by STAMINA trained HCPs in secondary care outpatient clinics. All men on ADT were recommended exercise 
and referred to exercise (where eligible) as an essential part of prostate cancer care, by trained HCPs, at diagnosis 
and follow-up appointments. Trained HCPs addressed patient barriers and facilitators to exercise using theory 
and evidence-based BCTs (e.g. problem solving, pros and cons, verbal persuasion about capability) and provided 
men with study details and materials (behaviourally informed leaflet on potential adverse effects of ADT, ben-
efits of exercise and lifestyle modification and information about the community exercise partner).
Eligible participants were referred to the research team for telephone consent and completion of a pre-exercise 
health screening questionnaire used in previous  trials17 (adapted for men on ADT). On completion, a baseline 
assessment assessing weight, height,  resting heart rate, blood pressure and functional capacity via chair sit to 
stand  test19 was carried out in the clinic by a research nurse before referral to the linked community exercise 
partner. The assessments were repeated at 12-weeks.
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The embedded training programme. Professional training. Eligible HCPs and ETs received behaviourally 
informed, face-to-face, practical skill-based training to: (1) improve knowledge (2) increase confidence, (3) 
change beliefs, (4) establish social norms, (5) develop behaviour change skills and (6) change beliefs of their 
perceived role to support patient exercise  behaviour20,21. HCP training was delivered within 7 days prior to the 
NHS sites recruitment start date and lasted a duration of half a day. ET training was delivered within 7 days post 
recruitment start date to reduce time between training and delivery of the exercise prescription (further details 
available in supplementary file 1).
The patient intervention. Supervised aerobic and resistance training were undertaken twice weekly for 
12 weeks at Nuffield Health as per National Institute of Health and Care Excellence recommendations (NG131 
1.4.19). The exercise prescription was tailored to account for the individual’s capability, opportunity and moti-
vation and (where appropriate) any relevant medications and co-morbidities using applicable clinical exercise 
prescription guidelines and results of a submaximal treadmill/ bike exercise test based on the modified Bruce 
 protocol22.
According to our previously published  data17, to facilitate optimum behaviour change, in those participants 
who need to overcome significant functional limitations due to comorbidity or lack of confidence in a public gym 
environment, we allocated a ’run in period’ which is a ramped approach to working towards the full intervention 
dose. This was tailored to each individual’s capability and is also an important safety aspect of our intervention 
design. These men were offered a reduced exercise prescription for (up to) the first 6-weeks, followed by 6 weeks 
according to protocol (12 weeks in total).
Supervised exercise sessions were delivered face-to-face by an ET,  one-to-one or in small groups (maximum, 
n = 5), with behavioural support (i.e. instruction, demonstration, prompting practise, feedback on behaviour, 
graded task). Each session consisted of an exercise programme that has been previously shown to be well-
tolerated and delivers clinically significant improvements in cancer specific QoL and fatigue  levels8. Briefly this 
entailed: 30–45 min of moderate intensity aerobic exercise and up to four sets and 8–12 repetitions of resistance 
exercises targeting major muscle groups. Exercise intensity was set at between 65 and 85% of age predicted heart 
rate or 3 to 5 on the 10-point Borg rating of perceived exertion (RPE)23. Heart rate and RPE were measured at 
5-min intervals and the exercise intensity amended where optimal heart rate was not achieved. Ongoing feed-
back on exercise technique and progressions were provided throughout the supervised sessions as appropriate.
Behavioural support was provided through an interactive patient workbook, ad hoc during supervised exer-
cise sessions and more formally at 6 and 12 weeks in progress reviews (with ETs) and follow-up care (with HCP). 
The primary focus was on integrating exercise into weekly routine (week 6) and maintaining lifestyle modifica-
tion (week 12) by utilising the following BCTs: feedback on behaviour, goal setting, review goals, prompt self-
monitoring, discuss social support and discuss habit formation. At 12 weeks, the sub-maximal exercise test was 
repeated, and a summary report was produced by the ETs and sent to the HCP team for review with the patient 
as part of their standard follow-up care. Behaviour change support was informed by theory and  evidence24, 
including evidence from a previously reported Cochrane review exploring interventions to improve exercise 
behaviour in people living with and beyond  cancer16. A simplified overview of the procedure can be seen in Fig. 1.
Outcome measures. Feasibility. Process data comprising recruitment; adherence to the intervention; 
study retention and adverse event rate were assessed by extracting data from screening and recruitment logs, 
attendance at supervised exercise sessions and exercise diary records, summary report completion and review 
of adverse event logs. Adverse events were defined according to international ethical, scientific and practical 
standards, i.e. Good Clinical  Practice25.
Acceptability. Acceptability of the interventions were explored in semi-structured interviews with (1) men on 
ADT for prostate cancer (purposively sampled to include variation in age, ADT duration, functional capacity, 
previous exercise behaviour, ethnicity), (2) HCPs in the prostate cancer care pathway (purposively sampled to 
include different team members) and (3) community-based ETs (sampled to include both personal trainers, 
physiologists, general managers and fitness managers). Interviews were led by an experienced facilitator (ES, SR, 
RT) and the topic guide was reviewed by the dedicated STAMINA Patient and Public involvement (PPI) group. 
Interviews explored the seven component constructs of the Theoretical Framework of Acceptability (TFA;26). 
Interviews were conducted post-intervention face-to-face or via telephone, dependent on participant conveni-
ence, and were audio recorded. Please see supplementary file 3 for topic guides.
Fidelity. Where acceptable and possible, interactions between patients and HCPs, and patients and ETs, were 
digitally audio-recorded (during initial appointment, six- and twelve-week reviews) as a measure of treatment 
fidelity i.e. to examine the ability of HCPs and ETs to perform treatment related behavioural skills and cognitive 
strategies in relevant real-life  contexts27.
Sample size. The sample size for this study was set to provide sufficient qualitative data to explore the 
feasibility, acceptability and fidelity of the STAMINA  intervention18 and as such a formal power calculation 
was not appropriate. We planned to recruit up to 40 men on ADT from up to 4 NHS sites and sample 32 audio 
recordings.
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Feasibility. Summary statistics were produced in Microsoft Excel, for eligibility, recruitment, retention, exer-
cise programme adherence and safety, and are presented as mean ± SD. The magnitude difference between exer-
cise test duration at baseline and 12 weeks was calculated using Cohen’s D and presented as an effect size.
Acceptability. Audio recordings were transcribed verbatim, checked for accuracy, and analysed deductively 
in Microsoft Excel, following the five stages of framework  analysis28 (ES). The analysis began by reading the 
interview transcripts then considering the relevance of the text to the domains of the Theoretical Framework of 
Acceptability (TFA). Text was attributed to more than one domain where applicable and data was coded inclu-
sively to maintain context throughout the analysis (i.e. text before and after the quote of interest was coded)29. In 
the final stages of analysis, each domain was described, and findings interpreted. Twenty five percent of coding 
was cross checked by a second and third independent reviewer to reduce researcher bias (RT, SR). Consensus on 
coding and interpretation was achieved via discussion.
Fidelity. A purposive sample of 32 audio recordings, reflecting different professionals (i.e. HCPs and ETs), dif-
ferent sessions (i.e. first, middle or last session) and different sites were rated by two independent researchers 
using checklists that were in development in line with  guidance27 (RT, SR, LS). Checklists included delivery and 
quality of delivery of target behaviours and BCTs specific to the HCP and ET role (See supplementary file 4). 
Delivery of each target behaviour and BCT were scored a maximum of 2 points (0 = poor, 1 = limited, 2 = good). 
Scores were combined and converted to a percentage to calculate an overall fidelity score. Levels of fidelity were 
reported in line with the literature as: 80–100% adherence interpreted as ’high fidelity’, 51–79% as ‘moderate’ 
and 0–50% as ‘low’  fidelity30,31. BCTs were advocated for use when patients expressed ambivalence or resistance 
towards exercise, and thus were not always applicable/ included in the analysis. Consensus on inclusion of BCTs 
was reached through discussion with LS, who has extensive experience in the coding of BCTs.
Results
Feasibility. Participant recruitment and retention. We recruited three NHS sites (located in South York-
shire, Derbyshire and North Somerset) and three community exercise partners between May and October 2019. 
Within this timeframe, a total of 33 HCPs were approached to take part in the STAMINA intervention due to 











Healthcare professional and 
Exercise professional training
Man on ADT begins exercise 
prescripon with supervision 
from an exercise professional
At 6 weeks, man on ADT has 
review with exercise 
professional
At 12 weeks, man on ADT has 
review with exercise 
professional and summary 
NHS clinician directly endorses 
exercise to man on ADT
Exercise professional reviews 
capabilies, comorbidies, sets 
goals and agrees exercise 
prescripon with man on ADT
Man on ADT follows exercise prescripon at community gym with exercise professional supervision for 12 weeks
Figure 1.  Overview of the study procedure.
5
Vol.:(0123456789)
Scientific Reports |        (2021) 11:12470  | https://doi.org/10.1038/s41598-021-91876-y
www.nature.com/scientificreports/
to take part in the intervention and remained within their role until study closure. Four (12%) did not engage 
with emails from the research team and/ or the principle investigator at site and three (9%) had insufficient time 
to participate. In total, 26 HCPs were recruited and provided written consent to deliver the STAMINA interven-
tion, including: Consultant Urologists (n = 8), Clinical Oncologists (n = 3), Clinical Nurse Specialists (n = 10), an 
Urological radiographer (n = 1), research nurses (n = 3) and a support worker (n = 1).
In parallel, a total of 24 ETs were approached to deliver the STAMINA intervention. Twenty (83%) provided 
informed consent before attending training, and four (17%) declined, due to insufficient time to participate. Four 
ETs later withdrew from the study due to personal reasons (n = 2) or termination of employment at Nuffield 
Health (n = 2). In total, 20 ETs were recruited to deliver the STAMINA intervention, including: community gym 
site managers (n = 2), fitness managers (n = 3), a physiologist (n = 1) and personal trainers (n = 14).
Between June 2019 and January 2020, forty-five men were eligible following initial screening and were pro-
vided with STAMINA study details. Three (7%) men declined participation and two (4%) men were subsequently 
excluded due to ineligibility. Of the remaining 40 men who completed further screening and baseline assessments, 
36 (90%) were eligible to receive the STAMINA intervention. Following referral, one man (3%) withdrew due to 
difficulties managing the side effects of radiotherapy (and did not attend any exercise sessions) leaving 35 men 
(97%) on ADT for prostate cancer who consented to receive the STAMINA intervention (Table 1).
The study was discontinued early due to the coronavirus pandemic. Furthermore, one participant’s exercise 
data was not returned. Data presented here are on the men who completed the 12-week intervention and returned 
data (n = 20) before a government mandated national lockdown was enforced in the UK from March 2020 (Fig. 2).
Study adherence. Twenty men on ADT completed the STAMINA intervention, defined as completion of base-
line and 12-week assessment in the NHS and 12 weeks of supervised exercise at the community-gym provider. 
Participants attended an average of 20 out of 24 scheduled supervised exercise sessions over 12 weeks (i.e. 83% of 
target). Reasons for non-attendance included: hospital appointments (4%), feeling unwell (18%), holidays (33%) 
and scheduling difficulties (46%). 25% of men were allocated a run-in period lasting between 4 and 6 weeks. 
Modifications were made to the frequency of sessions, from twice to once a week (n = 4), and to the type of 
exercise delivered, with one man starting with aerobic exercise only. In each prescribed session participants com-
pleted an average of 27.48 min (SD = 3.48) of aerobic exercise at 77% heart rate max (or RPE of 5), equating to 
92% of the prescribed dose (Fig. 3). Furthermore, participants completed 3 sets (SD = 0.41) of 10 reps (SD = 0.65) 
of 3 (SD = 0.90) resistance exercises per session.
Seventeen (85%) men completed the exercise test at baseline and 12-weeks. Three participants were unable to 
repeat the test at 12 weeks due to feeling unwell: one participant reported fatigue from radiotherapy treatment and 
two were unrelated to treatment or the disease. At baseline, participants achieved a mean of 6.56 min (SD = 2.71) 
in the exercise test. A 33% (d = 0.66) increase in test duration was demonstrated at 12 weeks (mean = 8.40 min; 
SD = 2.85), with minimal change in final heart rate (baseline = 133.00 ± 24.36; 12 weeks = 134.18 ± 18.57) and RPE 
(baseline = 5.94 ± 1.71; 12 weeks = 6.35 ± 1.66) (Fig. 4).
Table 1.  Baseline characteristics of men on ADT in the STAMINA trial.
Baseline measures
Age (mean ± SD) 72 ± 9 years
BMI (mean ± SD) 28.6 ± 4.2 kg  m2
Resting heart rate (mean ± SD) 69 ± 12 beats per minute
Diastolic BP (mean ± SD) 77.4 ± 10.1 mmHg
Systolic BP (mean ± SD) 137.4 ± 13.4 mmHg
ADT duration (mean ± SD) 7 ± 9 months
Ethnicity 100% self-report as White British or English
Chair sit-to-stand test (mean ± SD) 12 ± 4 reps
Self-report health status
Poor health (n = 0; 0%)
Unhealthy (n = 1; 3%)
Moderately healthy (n = 9; 25%)
Relatively good health (n = 26; 72%)
Self-report functional capacity
Get in and out of an armchair (n = 36; 100%)
Leave the house independently (n = 36; 100%)
Climb three flights of stairs unaided (n = 33; 92%)
Walk 100 yds (91 m) without stopping (n = 34; 94%)
Walk 1 mile (1.6 kms) without stopping (n = 28; 78%)
Jog 100 yds (91 m) without stopping (n = 21; 58%)
Jog 1 mile (1.6 kms) without stopping (n = 5; 14%)
Registered disabled Yes, n = 1 (3%)
Smoker Yes, n = 3 (8%)
Drink alcohol
Never (n = 3; 8%)
Occasionally (n = 27; 75%)
Once a day (n = 5; 14%)
More than once a day (n = 1; 3%)
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Number of paents eligible for study following 
inial screening of inclusion/ exclusion criteria by 
HCP and provided with study materials (n = 45) 
Eligible for study following telephone screening 
and invited for baseline tesng (n = 40) 
Reason for ineligibility following 
telephone screening (n = 2): 
-Due to commence chemotherapy 
within 3 months (n = 1) 
- Due to receive heart surgery (n = 
1) 
Reason for declining parcipaon
(n = 3)  
-Due to an addional health 
condion (n = 1) 
-Already physically acve (n = 1) 
-No reason provided (n = 1) 
Completed baseline assessment, informed 
consent and referred to community gym 
provider (n = 36)
Reason for ineligibility following 
baseline tesng (n = 4): 
-Bony metastases (n = 1) 
-Pre-exisng medical condion (n 
= 2) 
-Declined parcipaon (n = 1) 
Reason for withdrawal following 
referral to community gym (n = 1): 
-Withdrew due to side effects of 
radiotherapy (n = 1) 
Completed 12-week exercise intervenon 
with progress review at 6 and 12 weeks (n = 
20).  
Study disconnued due to 
government mandated naonal 
lockdown (n = 14)  
Research data not returned (n = 1) 
Submaximal exercise test repeated (n = 17), 
summary report produced and sent to HCP (n 
= 20) 
Figure 2.  STAMINA trial CONSORT diagram: Patient recruitment and retention.
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Feedback to clinical teams was high with ETs completing a summary report for all (100%) participants. Only 
5 out of 20 summary reports were discussed in follow-up care (i.e. 25% of target).
Adverse events. One serious adverse event, unrelated to the study, was reported during the intervention. The 
participant fainted at home, fracturing his ankle. Subsequent diagnostic tests were performed (i.e. echocardio-
gram and 24 h ECG) and reviewed by a cardiologist. The participant was deemed safe to continue exercising, and 
thus on healing of the injury, resumed the intervention. Additionally, four adverse events from three participants 
were reported over the duration of the trial. One was related to participation in the study and involved mild soft 






































Parcipants who completed the 12 week intervenon
Figure 3.  Average duration of aerobic exercise per session, in minutes for 20 participants. (Dashed line = 75% 













































Parcipants who completed the baseline and 12 weeks submaximal test
Figure 4.  Percentage change in submaximal test duration between baseline and 12 weeks for 17 participants.
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adverse events were unrelated to study participation (i.e. bruising from a fall at home, pain from a catheter and 
pain from gout).
Acceptability. Acceptability was explored in 22 planned interviews with participants who delivered (HCPs, 
n = 8; ETs, n = 6) and received the intervention (patients n = 8). Twelve interviews were conducted face-to-face 
and 10 via telephone. Selected quotes are presented in the 7 themes of the TFA  below26 (see Supplementary 5 
for full details).
Affective attitude. The men provided overwhelmingly positive reports of their experiences of participating in 
the STAMINA intervention, regardless of previous exercise experience. Positive reports were echoed by HCPs 
and ETs:
Yeah it was great actually because it was, for once it was something positive that we could offer to patients 
(HCPW1)
I just think it’s been phenomenal for their overall wellbeing (ETW1)
Excellent, excellent, from start to finish (PtC4)
Burden. The men thought that twice weekly supervised sessions were achievable, and some were keen to com-
plete additional independent exercise sessions. HCP and ETs required time to attend professional training but 
mostly felt they had sufficient time to provide behavioural support, embedded into their current role:
When we initially see the patients to start them on the hormone treatment, I’m talking through the pos-
sible side effects with them, so I’m already mentioning to them, you know, and to counteract these they 
need to be fit and active (HCPC1)
Been really easy actually to get them all booked in (ETC3)
I was looking forward to it. Never one day did I feel it was a bind (PtS5)
Ethicality. The intervention aligned with all participants values including their professional development goals 
and personal beliefs related to the importance and beneficial effects of exercise for men on ADT:
I think we all really believe in it, because it’s an area that has been lacking for patients in terms of informa-
tion and advice, but also resource (HCPS1)
We are here to help people. So yeah, I think it’s definitely the right kind of gym to do it. And the right 
range of trainers as well (ETC3)
When I was diagnosed originally, no I’d never give exercise a thought. If you’d said to me six month ago 
you’d be going to the gym I’d have laughed at you … but as Dr [name] told me, it’s manageable (PtC4)
Intervention coherence. All participants demonstrated a good understanding of the intervention components 
and intended study aims/ outcomes:
I think it gives them something positive. I think it allows them to take control (HCPS1)
So, we’ve seen cardiovascular improvements, strength improvements. I’m getting people coming to me 
going I’ve got a bit more energy now (ETC/S2)
If you go along with the right attitude and you’re prepared to put in as much effort as you people in getting 
it up together, you’ll get a lot out of it. (PtS5)
Opportunity costs. There were no perceived opportunity costs for patients. However, some clinic appointments 
were rescheduled to provide time for professional training and exercise delivery and some ETs extended their 
working hours to deliver the intervention off-shift in line with their preferences.
So, if we’re introducing a radiotherapy trial or a drug trial then we will spend more time in clinic talking 
to them about it. So, in a way it was no different (HCPW1)
For myself, it has meant some longer days (ETW1)
If I can’t find an hour and a half of my day to come and do this which is extending my life, that’s the way 
I look at it, I’d be a fool. I really would (PtS1)
Perceived effectiveness. All participants believe that supervised exercise has physical, psychological and social 
benefits for men on ADT, including a reduction in fatigue and improvements in QoL.
It was just something positive that we could say look we’ve got evidence that actually if you do supervised 
exercise then that may reduce the fatigue and improve your quality of life (HCPW1)
Psychologically it gets them out the house doesn’t it, so they’re not isolated. It gets them into an environ-
ment with a lot of people (ETC1)
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Self‑efficacy. Some participants expressed initial apprehensions about delivering or participating in the inter-
vention, however these were quickly addressed via professional training, experience, and ongoing support:
Not very. More confident now yeah, because I’ve got used to doing it (HCPC1)
With my particular role I felt OK, because that’s something that I do every day (ETS1)
I thought I wouldn’t be able to get anything out of it because of my [co-morbidity] but I was wrong. (PtC8)
Fidelity. A total of 78 interactions between patients and HCPs (n = 31), and patients and ETs (n = 47), were 
digitally audio-recorded. A purposive sample of 32 audio recordings were analysed reflecting interactions at 
referral (n = 16), induction to the gym (n = 6), six (n = 6) and twelve-week review (n = 4). HCPs at one NHS trust 
did not audio record any of their interactions with patients in live time. As such, these specific audio recordings 
could not be coded for fidelity or included in the analysis. Furthermore, all of the interactions between patients 
and ETs were marked down during the analysis due to a lack of clarity on the audio recording of whether the 
behaviour had been performed and/ or of its quality as it was delivered partly or wholly outside of the clinic 
room (i.e., the treadmill/ bike exercise test).
Fidelity of the HCP and ET role were found to be moderate (74%) and high (82%),  respectively26. Profession-
als scored more highly for the delivery, and quality, of target behaviours compared to the delivery, and quality, 
of applicable BCTs (Table 2).
Discussion
STAMINA is the first study to report on the feasibility and acceptability of a supervised exercise programme 
embedded into standard NHS prostate cancer care. We demonstrate that National Institute of Health and Care 
Excellence recommendations (NG131 1.4.19) can be delivered, by embedding exercise into the prostate cancer 
care pathway, in collaboration with community partners, thus addressing the large disconnect between what 
guidelines recommend as optimal care, and what patients receive. Furthermore, we demonstrate good feasibility, 
acceptability and fidelity in terms of recruitment, retention, adherence and delivery of behaviourally informed 
exercise support, with very few adverse events.
Our intervention design has provided preliminary data to suggest good uptake and retention to a super-
vised exercise programme embedded into prostate cancer care. Similar, findings have been demonstrated when 
supervised exercise is delivered in the community to breast cancer  survivors32. However, other community-based 
exercise programmes, such as cardiac rehabilitation, have experienced poor  uptake33,  retention34 and  adherence33 
with only half of patients being recommended exercise by their clinical team. The STAMINA intervention sought 
to address limitations observed in cardiac rehabilitation by providing skill-based professional training to rec-
ommend and refer men on ADT for exercise. For example, we identified and addressed HCP  barriers6 related 
to endorsing exercise and providing behavioural support to men on ADT. Subsequently, HCPs believed the 
intervention was likely to be effective and high levels of recruitment and retention were reported. For instance, 
all eligible participants completed the full intervention where possible, with the exception of one participant who 
discontinued due to side effects of radiotherapy, and this was very early on, i.e., after one session.
The exercise prescription was considered acceptable in a community-gym environment by men on ADT, 
with twice weekly supervision deemed the optimal frequency of exercise training. Adherence to the exercise pre-
scription was high, with most men achieving the prescribed exercise dose (intensity and volume) and attending 
most scheduled sessions. Some participants were allocated a tailored run-in period, demonstrating community-
based ETs skills to deliver a bespoke, safe and effective exercise programme based on an individual’s capability, 
opportunity and  motivation24. Similar results were previously reported in two RCTs delivering combined aerobic 
and resistance training  with8 or  without11 dietary advice to men on ADT for prostate cancer. The high levels of 
adherence to, and acceptability of, the present intervention suggest no alterations to the exercise prescription are 
required ahead of the planned definitive RCT. Furthermore, results from the submaximal exercise test imply that 
the exercise prescription had a positive impact on physical fitness and endurance which may reduce the decline 
in physical function observed with  ADT35 in line with what has previously been reported in systematic  reviews15.
Table 2.  Fidelity of HCP and ET audio recorded consultations with men on ADT. a Delivery, and quality 
of delivery of target behaviours and behaviour change techniques were scored a maximum of 2 points 
each (0 = poor delivery; 1 = limited delivery; 2 = good delivery). Scores were combined and converted to a 
percentage (high fidelity = 80–100%; moderate fidelity = 51–79%; low fidelity = 0–50%). b Scores for delivery of 
target behaviours, quality of target behaviour delivery, delivery of behaviour change techniques and quality 
of behaviour change technique delivery were combined and converted to a percentage to provide an overall 
fidelity score (high fidelity = 80–100%; moderate fidelity = 51–79%; low fidelity = 0–50%).
HCP (n = 16) ET (n = 16) Total (n = 32)
Delivery of target  behavioursa 77% 88% 81%
Quality of target behaviour  deliverya 76% 84% 80%
Delivery of behaviour change  techniquesa 62% 77% 73%
Quality of behaviour change technique  deliverya 44% 70% 65%
Total level of  adherenceb 74% (moderate) 82% (high) 78% (moderate)
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Overall, the intervention content was delivered with moderate to high fidelity, i.e., HCPs and ETs demon-
strated good application and delivery of the skills learnt in training into real-life context. This in turn may facili-
tate the implementation of our behaviour change intervention into clinical  practice36 and provide confidence 
that changes in study outcomes will likely be due to the intervention and not variability in  implementation37. 
However, as demonstrated  previously38 we identified an inherent limitation in the data capture technique and 
subsequent analysis. For example, acceptability of the measurement approach (particularly in HCPs) was poor, 
with audio recordings acting as a barrier to intervention delivery, indicating a clear division between research 
and practise, as previously  reported39. Therefore, fidelity of the intervention and acceptability of the research tool 
may be improved by designing an additional/ alternative measure that considers both psychometric (i.e. validity 
and reliability) and implementation qualities (i.e. acceptability and user-friendliness)40, or assessing fidelity post 
training using role model scenarios.
Embedding exercise into the prostate cancer care pathway was deemed highly acceptable by participants 
who delivered and received the intervention, aligning with their values and beliefs about exercise as a treatment 
 component26. Through experience and professional training, HCPs and ETs were able to integrate behavioural 
support into routine clinic discussions and exercise sessions confidently, thus demonstrating the importance of 
professional behaviour change facilitated by intervention development  approaches24. Our acceptability data lends 
considerations for implementation. For example, managerial support and time is required to attend professional 
training, and ETs require protected time to deliver the intervention on shift to reduce extensive working hours. 
The next step is to evaluate the clinical and cost effectiveness of embedding exercise into routine prostate cancer 
care in a planned definitive trial exploring maintenance of exercise and long-term behaviour change.
There are limitations to the present study that should be noted. This was a non-confirmatory, non-randomised 
prospective cohort study and as such all data is to be taken as preliminary. Our findings are primarily for the 
purpose of intervention development, refinement, and optimisation. The study was discontinued early due to the 
coronavirus pandemic and thus 14 men were unable to complete the intervention. Furthermore, only a quarter 
of progress reports were discussed in NHS follow-up appointments due to variability of care (e.g., follow-up care 
delivered by a non-STAMINA trained HCP) and problems in the electronic communication pathway (e.g., dif-
ficulty uploading the progress report into patient notes). Also, we did not encourage men to generalise behaviours 
learnt in supervised exercise environments to other non-supervised contexts, which may influence long-term 
adherence and habit formation in a longer trial. Despite the limitations, we captured sufficient qualitative data 
to explore the feasibility, acceptability and fidelity of the STAMINA intervention as originally planned. How-
ever, the impact of societal changes due to the pandemic creates uncertainty regarding the future of face-to-face 
interventions. Telemedicine is anticipated to play an increasing role in healthcare and is rapidly being adopted by 
healthcare services with potential for extension to clinical exercise services for people with  cancer41. Furthermore, 
delivery of remote supervised exercise could circumvent financial pressures of exercise services and provide a 
scalable service independent of residential location. However, currently there is insufficient evidence to support 
efficacy of remote exercise programmes and thus this warrants further  exploration42.
Conclusion
The STAMINA intervention, which is designed to embed clinical guidance around exercise training into standard 
prostate cancer care to optimise management of men on ADT demonstrated good feasibility and acceptability. 
Men on ADT reported positive impacts on lifestyle behaviours and measures of physical fitness and function. 
Furthermore, the intervention was deemed highly acceptable by HCPs, ETs and men on ADT. Some research 
processes, particularly around fidelity assessment, need to be refined. The intervention (with few adaptations) 
has been shown to be suitable for evaluation of clinical and cost-effectiveness in a planned definitive randomised 
clinical trial.
Data availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files).
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